Study of GS-4528 in Adults With Solid Tumors
This important study is looking into a new treatment called GS-4528 for adults who have solid cancers. Researchers are testing GS-4528 by itself and also alongside another drug called Zimberelimab. The main goals are to check if these treatments are safe and if people can tolerate them well. They also want to find the best and safest dose of GS-4528 to use in the future, both on its own and when given with Zimberelimab. This type of early study helps doctors understand how new medicines work in the body before they can be used more widely, offering hope for new ways to fight cancer.
Em resumo
Sobre o que é este estudo?
This clinical study is like an early step in finding new treatments for solid cancers. Researchers are focusing on a new drug called GS-4528. They want to see how safe it is and how well people can tolerate it. They are testing GS-4528 in two ways: first, on its own, and second, in combination with another approved cancer drug called Zimberelimab. This is important because combining treatments can sometimes be more effective than using just one.
The main purpose of this study is to find the right amount, or 'dose,' of GS-4528 that works best while still being safe. They will test different doses to make sure it's well-tolerated. Finding the right dose is key for any new medicine. This study is aimed at adults who have solid cancers.
By taking part, individuals contribute to medical knowledge and help researchers understand if GS-4528 could become a useful new treatment option in the future. This kind of research is vital for developing better ways to treat cancer and improve patients' lives, even though it's an early stage of investigation.
Pontos principais
- This study is for adults with solid cancers that haven't responded to, or can't receive, other treatments.
- It's testing a new drug, GS-4528, alone or with Zimberelimab, to check safety and find the best dose.
- Participation involves regular clinic visits, blood tests, scans, and tissue samples.
- This is an early-stage (Phase 1) study focused on understanding how the new drug works.
- Você pode se retirar do estudo a qualquer momento.
- The study helps develop potential new cancer treatments for the future.
Quem pode ser elegível?
To join this study, you would generally need to be an adult with a solid tumour that has either not responded to other treatments, or you couldn't take those treatments, or they caused too many problems. We would also need to see that your general health is good, for example, your body's organs like your liver and kidneys are working well.
You would need to have cancer that we can measure properly, usually with scans. Also, if you are a woman who could become pregnant, you would need to agree to use effective birth control during the study.
There are also reasons why someone might not be able to join. For example, if you are pregnant or breastfeeding, or if you've recently had other major cancer treatments, surgery, or radiation therapy within a certain time frame. Having certain other medical conditions or having had a transplant in the past would also prevent you from joining.
Este estudo pode ser adequado para você?
Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.
- Are you an adult with a solid cancer?
- Has your cancer either not responded to other treatments, or are you unable to take them?
- Is your general health, including your organ function, considered good?
- If you are a woman able to have children, are you willing to use birth control?
- Have you not had any major cancer treatments (like surgery, chemo, radiation) very recently?
- Você não está grávida ou amamentando?
O que envolve a participação?
If you decide to take part in this study, you would first have a thorough check-up to make sure you're eligible. During the study, you would receive the new drug, GS-4528, either on its own or in combination with Zimberelimab. This would involve regular visits to the clinic for medical examinations, blood tests, and scans to monitor your health and how the treatment is affecting you and your cancer. You would also need to provide a small sample of your tumour tissue before starting the treatment.
For some participants, an additional tumour sample might be needed during the treatment to look at how the drug is working. The study team would closely monitor you for any side effects and manage them as needed. The total duration of your participation would be explained by the study team, and it would involve ongoing check-ins and follow-up appointments.
Riscos e benefícios potenciais
Localizações (16)
- The University of Washington/FHCCCódigo postal verificadoSeattle, Estados Unidos
- O Hospital de OttawaCódigo postal verificadoOttawa, Canadá
- University Health Network, Princess Margaret Cancer CentreCódigo postal verificadoToronto, Canadá
- Asan Medical CenterCódigo postal verificadoSeoul, South Korea
- Severance Hospital, Yonsei University Health SystemsCódigo postal verificadoSeoul, South Korea
- Samsung Medical CenterCódigo postal verificadoSeoul, South Korea
- NEXT Oncology-Hospital Quironsalud Barcelona - Unidad de Ensayos Fase 1Código postal verificadoBarcelona, Espanha
- Hospital Universitari Vall D'Hebron- Oncology ServiceCódigo postal verificadoBarcelona, Espanha
- START MADRID_Hospital Universitario Fundacion Jimenez Diaz - Unidad de Ensayos Fases ICódigo postal verificadoMadrid, Espanha
- START MADRID_HM Sanchinarro-CIOCC-Unidad de Ensayos Fases ICódigo postal verificadoMadrid, Espanha
- Clinica Universidad de Navarra- Unidad Central de Ensayos ClinicosCódigo postal verificadoPamplona, Spain
- Taichung Veterans General HospitalCódigo postal verificadoTaichung, Taiwan
Perguntas frequentes
What is a 'solid tumour'?
A solid tumour is a mass of abnormal tissue that doesn't contain cysts or liquid areas, like cancers of the lung, breast, or bowel.
What does a 'Phase 1' study mean?
A Phase 1 study is the first stage of testing a new drug in people. It mainly checks if the drug is safe, if people can tolerate it, and what the best dose might be.
What is 'monotherapy'?
Monotherapy simply means that you would receive only one treatment (GS-4528) by itself, without other cancer drugs at the same time.
Will I know if I'm getting GS-4528 alone or with Zimberelimab?
The study team will explain exactly which treatment group you would be in and what drugs you would receive.
What are 'measurable disease' and 'organ function'?
Measurable disease means your cancer can be accurately sized, usually on scans. Good organ function means your body's main organs are healthy enough to take part in the study.
Como saber mais
Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.
Discussão
Discussão da comunidade
Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.